Categories AlphaGraphs, Earnings, Retail

Revlon reports declining sales; net loss widens

Cosmetics company Revlon (REV) reported declines in top and bottom line results, primarily hurt by steep fall in sales in North America. However, international growth was a big positive for the Elizabeth Arden segment compared to other segments, gaining 2.3% year-over-year. Net loss more than doubled to $76.9 million or $1.46 per share from the year ago loss of $36.5 million or $0.70 per share, impacted by the US corporate tax cuts. Excluding special items, the company lost $0.86 per share compared to a gain of $0.43 per share a year ago.

Across all geographical segments, international was a bright spot for Professional and Elizabeth Arden segments, which gained 8.5% and 20.7% respectively in sales, while Consumer and Other segments declined 1.5% and 23.4% respectively.

Elizabeth Arden Integration

Revlon said it is continuing to speed up the realization of synergies and cost cuts on the restructuring and consolidation of Elizabeth Arden, delivering $69 million of synergies and cost reductions for 2017 vs. the expected amount of $55 million to $60 million.

Revlon earnings

Most Popular

Key highlights from Eli Lilly’s (LLY) Q1 2024 earnings results

Eli Lilly and Company (NYSE: LLY) reported first quarter 2024 earnings results today. Worldwide revenue was $8.77 billion, up 26% from the year-ago quarter, driven by increases of 16% in

MCD Earnings: Key quarterly highlights from McDonald’s Q1 2024 financial results

McDonald's Corporation (NYSE: MCD) reported first quarter 2024 earnings results today. Revenues increased 5% year-over-year to $6.1 billion. Revenue growth was 4% in constant currencies. Net income grew 7% to

KO Earnings: All you need to know about Coca-Cola’s Q1 2024 earnings results

The Coca-Cola Company (NYSE: KO) reported its first quarter 2024 earnings results today. Net revenues grew 3% year-over-year to $11.3 billion. Organic revenues grew 11%. Net income attributable to shareowners

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top